Characteristic | No (%) |
---|---|
Total | 107 |
Age (y) | 4.268 ± 3.294 |
Gender, No. (%) | |
 Male | 55(51.40) |
 Female | 52(48.60) |
Underlying diseases, No. (%) | |
 None | 98(91.59) |
 Congenital heart disease | 5(4.67) |
 Congenital biliary atresia | 2(1.87) |
 Other diseases | 2(1.87) |
Symptoms and signs | |
 Fever, No. (%) | 100(93.46) |
 Duration of fever (d) | 7.690 ± 5.770 |
 Cough, No. (%) | 107(100) |
 Wheezing, No. (%) | 20(18.69) |
 Duration of wheezing (d) | 0.00(0.00,5.00) |
RMPP, No. (%) | 56(52.34) |
Hypoxemia, No. (%) | 16(14.95) |
Mechanical ventilation, No. (%) | 7(6.54) |
Application of glucocorticoids, No. (%) | 60(56.07) |
Replacement of antibiotics, No. (%) | 19(17.76) |
7-day course of azithromycin, No. (%) | 42(39.25) |
Coinfection, No. (%) | 60(56.07) |
MP with A2063G mutation, No. (%) | 60(56.07) |
Prognosis after treatment, No. (%) | |
 Surviving | 105(98.13) |
 Nonsurviving | 2(1.87) |